Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
111-133
Author(s):
Andrea Amalfitano and Robin J. Parks
Adenovirus As An Integrating Vector
Journal:
Current Gene Therapy
Volume:
2
Page:
135-144
Author(s):
K. Mitani and S. Kubo
CFTR Gene Transfer to Lung Epithelium - On the Trail of a Target Cell
Journal:
Current Gene Therapy
Volume:
2
Page:
173-181
Author(s):
S. O'Dea and D. J. Harrison
Bone Marrow Stromal Cells as Targets for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
195-209
Author(s):
An Van Damme, Thierry Vanden Driessche, Desire Collen and Marinee K.L. Chuah
The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy
Journal:
Current Gene Therapy
Volume:
2
Page:
211-226
Author(s):
Andreas Hombach, Claudia Heuser and Hinrich Abken
Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
Journal:
Current Gene Therapy
Volume:
2
Page:
227-234
Author(s):
Thomas Licht and Chrisitian Peschel
Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Recent Advances in the Chemistry and Biology of Folypoly-γ-glutamate Synthetase Substrates and Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
331-355
Author(s):
Aleem Gangjee, Nauzer P. Dubash, Yibin Zeng and John J. McGuire
Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
387-401
Author(s):
M. Tolomeo and D. Simoni